CSL share price rebounds as inflation cools; ASX:CSL turns to February results and RBA call

CSL share price rebounds as inflation cools; ASX:CSL turns to February results and RBA call

SYDNEY, Jan 7, 2026, 16:56 (AEDT) — After-hours

  • CSL shares finished higher after Tuesday’s sharp slide, but remain near yearly lows
  • Fresh inflation data put Australia rate expectations back in focus
  • Next milestones: late-January CPI, early-February RBA decision, and CSL’s February results

CSL Ltd shares closed up 1.0% at A$170.00 on Wednesday. The biotech heavyweight recovered some ground after sliding 2.4% in the prior session as Australian stocks steadied after a softer inflation reading. The stock traded between A$168.65 and A$170.52 and is down about 41% over the past year, hovering near its 52-week low of A$168.00.

CSL’s move matters for the local market because the company is a major weight in the S&P/ASX 200 and a bellwether for Australia’s health care sector. With the share price pinned near its yearly trough, investors are sensitive to any shift in rate expectations and to signs that earnings momentum is stabilising.

The next big test is CSL’s half-year report in February, which will reset guidance expectations for the year and shape dividend thinking. In the meantime, markets are treating inflation as the key swing factor for the Reserve Bank of Australia’s first policy decision of 2026.

The consumer price index rose 3.4% in the 12 months to November, down from 3.8% in October, the Australian Bureau of Statistics said on Wednesday. Trimmed mean inflation — a measure of underlying price pressure that strips out big swings — eased to 3.2%, and the ABS said it will publish December figures and quarterly CPI on Jan. 28.

Westpac chief economist Luci Ellis called the print a “very pleasant surprise” for headline CPI, but said the data still carried “a lot of noise” as electricity rebates roll through prices. NAB chief economist Sally Auld said some sticky drivers, including rents, were still running “a little bit too hot”. ABC

CSL’s financial calendar shows it will report half-year results and announce an interim dividend on Feb. 11. It has flagged March dates for the stock to trade ex-dividend — when new buyers no longer qualify for the payout — and for the record date and payment in early April.

For rates, the RBA’s monetary policy board meets Feb. 2–3 and is due to issue its decision statement at 2:30 p.m. AEDT on Feb. 3, with minutes scheduled for Feb. 17. The sequencing leaves investors little time to absorb the Jan. 28 CPI update before the central bank speaks.

Technically, CSL is trying to build a base just above its 52-week low. A clear break below that level would keep the downtrend intact, while a move back through this week’s highs would ease pressure ahead of earnings.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Bitcoin price today slips near $93,000 as Morgan Stanley ETF filing puts Coinbase, Strategy stock in focus
Previous Story

Bitcoin price today slips near $93,000 as Morgan Stanley ETF filing puts Coinbase, Strategy stock in focus

Glencore stock steadies as copper hits record highs — what to watch next for GLEN.L
Next Story

Glencore stock steadies as copper hits record highs — what to watch next for GLEN.L